Adherence to drug treatment regarding the users of psychosocial attention centers with mood disorders and schizophrenia
DOI:
https://doi.org/10.11606/issn.1806-6976.v11i4p224-233Keywords:
Medication Adherence; Schizophrenia; Mood DisordersAbstract
The objective was to identify the prevalence and factors associated with non-adherence to psychiatric medication among users of Psychosocial Attention Centers. Dealing with a cross-sectional study, sheltering a prospective cohort of 563 users of Psychosocial Attention Centers in Pelotas. Household interviews were conducted and two questionnaires were applied. The prevalence of lack of accession was 32%, without significant differences according to gender, income, time of illness, diagnosis and type of medicine. Young individuals with higher education, with a partner, less frequent at the Psychosocial Attention Centers and with adverse effects, were least adherent to treatment. The lack of adhesion of the participants is mainly related to the adverse effects. Health policies need to focus on addressing this issue, proposing new strategies of adherence to treatments.